{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:02:50Z","timestamp":1793473370062,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>By whole-exome sequencing, we found the heterozygous <jats:italic>POLG<\/jats:italic> variant c.3542G&gt;A; p.Ser1181Asn in a family of four affected individuals, presenting with a mixed neuro-myopathic phenotype. The variant is located within the active site of polymerase gamma, in a cluster region associated with an autosomal dominant inheritance. In adolescence, the index developed distal atrophies and weakness, sensory loss, afferent ataxia, double vision, and bilateral ptosis. One older sister presented with Charcot-Marie-Tooth-like symptoms, while the youngest sister and father reported exercise-induced muscle pain and proximal weakness. In none of the individuals, we observed any involvement of the central nervous system. Muscle biopsies obtained from the father and the older sister showed ragged-red fibers, and electron microscopy confirmed mitochondrial damage. We conclude that this novel <jats:italic>POLG<\/jats:italic> variant explains this family\u2019s phenotype.<\/jats:p>","DOI":"10.1186\/s42466-022-00169-w","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T03:04:54Z","timestamp":1643684694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Heterozygous POLG variant Ser1181Asn co-segregating in a family with autosomal dominant axonal neuropathy, proximal muscle fatigability, ptosis, and ragged red fibers"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5320-9807","authenticated-orcid":false,"given":"Maike F.","family":"Dohrn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Zengeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-8215","authenticated-orcid":false,"given":"Carolin D.","family":"Obermaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Biskup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nikolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristl G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Sch\u00f6ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-7644","authenticated-orcid":false,"given":"Danique","family":"Beijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Gess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Mulahasanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"5","key":"169_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbabio.2008.10.007","volume":"1787","author":"SS Chan","year":"2009","unstructured":"Chan, S. S., & Copeland, W. C. (2009). DNA polymerase gamma and mitochondrial disease: Understanding the consequence of POLG mutations. Biochimica et Biophysica Acta, 1787(5), 312\u2013319.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"169_CR2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/archneur.60.9.1279","volume":"60","author":"M Filosto","year":"2003","unstructured":"Filosto, M., Mancuso, M., Nishigaki, Y., Pancrudo, J., Harati, Y., Gooch, C., Mankodi, A., Bayne, L., Bonilla, E., & Shanske, S. (2003). Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase \u03b3. Archives of Neurology, 60(9), 1279\u20131284.","journal-title":"Archives of Neurology"},{"issue":"2","key":"169_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1021\/cr040463d","volume":"106","author":"MA Graziewicz","year":"2006","unstructured":"Graziewicz, M. A., Longley, M. J., & Copeland, W. C. (2006). DNA polymerase \u03b3 in mitochondrial DNA replication and repair. Chemical Reviews, 106(2), 383\u2013405.","journal-title":"Chemical Reviews"},{"issue":"8","key":"169_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/jnnp.2003.025890","volume":"75","author":"S Kiechl","year":"2004","unstructured":"Kiechl, S., Horvath, R., Luoma, P., Kiechl-Kohlendorfer, U., Wallacher-Scholz, B., Stucka, R., Thaler, C., Wanschitz, J., Suomalainen, A., & Jaksch, M. (2004). Two families with autosomal dominant progressive external ophthalmoplegia. Journal of Neurology, Neurosurgery and Psychiatry, 75(8), 1125\u20131128.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"169_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.10278","volume":"52","author":"E Lamantea","year":"2002","unstructured":"Lamantea, E., Tiranti, V., Bordoni, A., Toscano, A., Bono, F., Servidei, S., Papadimitriou, A., Spelbrink, H., Silvestri, L., & Casari, G. (2002). Mutations of mitochondrial DNA polymerase \u03b3A are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Annals of Neurology, 52(2), 211\u2013219.","journal-title":"Annals of Neurology"},{"issue":"1","key":"169_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42466-020-00064-2","volume":"2","author":"HC Lehmann","year":"2020","unstructured":"Lehmann, H. C., Wunderlich, G., Fink, G. R., & Sommer, C. (2020). Diagnosis of peripheral neuropathy. Neurological Research and Practice, 2(1), 1\u20137.","journal-title":"Neurological Research and Practice"},{"issue":"4\u20135","key":"169_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.nmd.2016.02.008","volume":"26","author":"M Mancuso","year":"2016","unstructured":"Mancuso, M., Orsucci, D., Angelini, C., Bertini, E., Carelli, V., Comi, G. P., Federico, A., Minetti, C., Moggio, M., & Mongini, T. (2016). \u201cMitochondrial neuropathies\u201d: A survey from the large cohort of the Italian Network. Neuromuscular Disorders, 26(4\u20135), 272\u2013276.","journal-title":"Neuromuscular Disorders"},{"key":"169_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbacli.2017.04.001","volume":"7","author":"A Nurminen","year":"2017","unstructured":"Nurminen, A., Farnum, G. A., & Kaguni, L. S. (2017). Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database. BBA Clin, 7, 147\u2013156.","journal-title":"BBA Clin"},{"issue":"18","key":"169_CR9","doi-asserted-by":"publisher","first-page":"15225","DOI":"10.1074\/jbc.C200100200","volume":"277","author":"MV Ponamarev","year":"2002","unstructured":"Ponamarev, M. V., Longley, M. J., Nguyen, D., Kunkel, T. A., & Copeland, W. C. (2002). Active site mutation in DNA polymerase \u03b3 associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. Journal of Biological Chemistry, 277(18), 15225\u201315228.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"169_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","volume":"15","author":"S Rahman","year":"2019","unstructured":"Rahman, S., & Copeland, W. (2019). POLG-related disorders and their neurological manifestations. Nature Reviews. Neurology, 15(1), 40\u201352.","journal-title":"Nature Reviews. Neurology"},{"issue":"25","key":"169_CR11","doi-asserted-by":"publisher","first-page":"17395","DOI":"10.1074\/jbc.274.25.17395","volume":"274","author":"TA Steitz","year":"1999","unstructured":"Steitz, T. A. (1999). DNA polymerases: Structural diversity and common mechanisms. Journal of Biological Chemistry, 274(25), 17395\u201317398.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"169_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/jnnp-2013-306799","volume":"86","author":"M Tchikviladz\u00e9","year":"2015","unstructured":"Tchikviladz\u00e9, M., Gilleron, M., Maisonobe, T., Galanaud, D., Lafor\u00eat, P., Durr, A., Eymard, B., Mochel, F., Ogier, H., & B\u00e9hin, A. (2015). A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity. Journal of Neurology, Neurosurgery and Psychiatry, 86(6), 646\u2013654.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-022-00169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-022-00169-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-022-00169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T03:08:10Z","timestamp":1643684890000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-022-00169-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1186\/s42466-022-00169-w","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained the patients\u2019 written consent for molecular genetic analyses and further scientific use, as well as for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Maike F. Dohrn has received scientific funding from Pfizer (ASPIRE 2018), has served as a paid consultant for Amicus, Akcea, Alnylam, and Pfizer, and is currently receiving a scholarship for a research fellowship by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). J\u00f6rg B. Schulz serves at advisory boards for Biogen and Roche. Burkhard Gess received financial support from Pfizer, Grifols, and Bayer for conference contributions. Natalie Winter has received scientific funding from Pfizer (ASPIRE 2018), has served as a paid consultant for Canon and Pfizer, and is currently receiving an intramural scholarship for a research fellowship (Clinician Scientist). CH, DZ, CDO, SB, JW, KGC, US, PA, and LM have no conflicts to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}